🎯 KEY DECISION: Clinical expert's final choices (Green)
🔧 AI REASONING: Click to see how the system works (expandable)
Optimizing Site Portfolio for Maximum Recruitment Efficiency
With the protocol finalized, the focus shifts to identifying and selecting the optimal mix of sites to meet recruitment targets while ensuring data quality and regulatory compliance.
Michael Rodriguez, Director of Clinical Operations
Company: Mid-size biotech with promising SGLT2 inhibitor
Challenge: Optimize site portfolio for maximum recruitment efficiency and data quality
Target: 67 sites to recruit 12,000 patients over 42 months
1
Site Performance Analysis Request
Michael Rodriguez's Request: "Identify optimal sites for cardiovascular outcomes trial, target 65 sites, need 190 patients per site over 42 months"
1. Query Ontological Mapping: Maps "cardiovascular outcomes trial" to formal CTO concepts and retrieves protocol parameters
2. Site Performance Ontology Activation: Accesses structured representations of site capabilities and performance history
3. Multi-Criteria Filtering: Applies ontological reasoning to filter sites using formal criteria
4. Performance Metric Integration: Standardizes performance metrics across different data sources
5. Contextual Enrichment: Enriches site data with protocol-specific context
Quick reaction: How do you currently identify and evaluate potential trial sites?
2
Multi-Criteria Optimization
Optimization Results:
• Tier 1 Sites (Academic): 25 sites, high data quality, slower recruitment
• Tier 2 Sites (Community Cardiology): 30 sites, faster recruitment, standard quality
• Tier 3 Sites (Primary Care Networks): 10 sites, geographic coverage, screening focus
• Geographic distribution: Ensures regulatory compliance and population diversity
How does the system optimize site selection?
EXPAND+
1. Multi-Objective Optimization Setup: Defines optimization problem using ontological constraints
2. Site Clustering Analysis: Classifies sites into tiers based on formal characteristics
3. Trade-off Modeling: Models performance trade-offs using causal relationships
4. Portfolio Optimization: Uses mathematical optimization with ontological constraints
5. Regulatory Validation: Cross-references with regulatory requirements
💭 Quick question: What's your biggest challenge in site selection?
3
Risk Assessment and Mitigation
Risk Analysis:
• 15% of proposed sites have competing trials in same population
• 3 high-volume sites have recent GCP audit findings
• Geographic clustering in Northeast may limit population diversity
Mitigation Recommendations:
• Alternative sites identified for high-competition areas
• Enhanced monitoring plan for sites with audit history
• Targeted recruitment in underrepresented regions
How does the system assess and mitigate risks?
EXPAND+
1. Risk Ontology Activation: Accesses formal risk categories with associated probability models
💭 Quick question: What's your biggest concern when assessing site risks?
4
Site Selection Decision
Final Selection: 67 sites selected (65 primary + 2 backup), balanced across tiers and regions. System prediction: 95% probability of meeting recruitment timeline with selected site portfolio
Updated System Projections:
• Expected enrollment rate: 8.2 patients per site per month
• Timeline confidence: 95% probability of meeting 42-month target
• Data quality score: 4.7/5.0 across selected sites
• Geographic diversity: 85% of FDA regions covered
How does the system validate the final selection?
EXPAND+
1. Decision Integration: Captures site selections and maps them back to Site Performance Ontology
2. Portfolio Validation: Uses Monte Carlo simulation to predict recruitment timeline probability
3. Constraint Satisfaction Verification: Validates final selection meets all ontological constraints
4. Predictive Model Generation: Generates confidence prediction using ensemble models